 This study found that fungenia caused by rare yeast species other than Candida had increased over time at a tertiary care university hospital. The most common yeast species identified were trichosporinosawhii and saprochiclovata. Azole-minimum inhibitory concentrations, mykes, were low for both species, while fluconazole and echinocandin mykes were high. Empirical antifungal therapy was liposomal amphotericin B for seven patients and voriconazole for four patients. Overall, 10 patients survived and 16 patients died. Patients with hematological malignancies had a higher mortality rate compared to those without. This article was authored by Dilsat Teep, Ferdub's AKSOI, Gerdl Jilmaz, and others.